Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Financial News

ContraVir completes follow-on

April 27, 2017 9:12 PM UTC

Infectious disease company ContraVir Pharmaceuticals Inc. (NASDAQ:CTRV) raised $12 million on April 25 through the sale of 12 million shares at $1 in a follow-on underwritten by Canaccord Genuity and ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Hepion Pharmaceuticals Inc.